Oakworth Capital, Inc. Takeda Pharmaceutical CO LTD Transaction History
Oakworth Capital, Inc.
- $1.43 Billion
- Q1 2025
A detailed history of Oakworth Capital, Inc. transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Oakworth Capital, Inc. holds 114 shares of TAK stock, worth $1,622. This represents 0.0% of its overall portfolio holdings.
Number of Shares
114Holding current value
$1,622% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding TAK
# of Institutions
359Shares Held
67.3MCall Options Held
1.72MPut Options Held
186K-
Capital Research Global Investors Los Angeles, CA13.2MShares$188 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.7MShares$81.1 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY5.32MShares$75.7 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.5MShares$49.9 Million0.57% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.43MShares$48.9 Million0.1% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $44.2B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...